Catamaran Bio Cambridge. Alvin Shih as President and Chief Executive Officer. Catamaran Bio headquarters is located at 610 Main St Cambridge.
Catamaran Bio is developing novel off-the-shelf CAR-NK cell therapies designed to treat a broad range of cancers including solid tumors. Catamaran Bio unveiled Monday has been quietly incubating at LabCentral in Cambridge since July and has 42 million raised by five venture capital firms. Manager Lab Operations.
Alvin Shih as President and Chief Executive Officer.
Based biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer launched with. Alvin Shih as President and Chief Executive Officer. Manager Lab Operations. November 23 2020 Catamaran Bio a Cambridge Mass-based developer of developing allogeneic CAR-NK cell therapies to treat cancer raised 42 million in Series A fundingSofinnova Partners and Lightstone Ventures co-led and were joined by Takeda Ventures Astellas Venture Management and founding backer SV Health Investors.
